Isera Lifesciences Limited - information technology in Pune City, Maharashtra, India. FY 2026 financials and compliance.
CIN L72200PN1993PLC252720 Incorporated 27 January 1993 ROC Pune HQ Pune City, Maharashtra, India
Active Listed - BSE: 534920 Public Limited Company information technology
Data last updated
Revenue · FY 2026
₹1.36 Cr
Exchange filings
Computed EBITDA · FY 2026
₹33.64 Lakh
▲ 142.01% YoY
Net profit · FY 2026
₹25.94 Lakh
▲ 86.62% YoY
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹8.41 Cr
Issued & subscribed
Open charges
None
Satisfied ₹1.6 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
1
Latest available

About Isera Lifesciences Limited

Data last updated: 14 July 2026

Isera Lifesciences Limited is a public limited company based in Pune City, Maharashtra, India. It specialises in application development and software solutions, a part of the broader technology and IT services sector. Incorporated on 27 January 1993, the company has been in operation for over 33 years.

Registered with ROC Pune under CIN L45400AP1993PLC015306. Listed on BSE: 534920.

Capital: an authorised share capital of ₹25 Cr and a paid-up capital of ₹8.41 Cr. Formerly known as Aarya Consultants Private Limited and Fastrak Industries Limited. It is led by directors including Mangina Rao Srinivas and Jitendra Prabhakar Nene.

Last AGM: 26 August 2025. Financial statements filed for year ended 31 March 2025. Office: Pune City, Maharashtra.

As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹1.36 Cr. The net worth stands at ₹8.25 Cr (up 8515.41% YoY). Total assets are valued at ₹10.56 Cr (up 579.8% YoY).

The company has a workforce of approximately 1 employees as per the latest available data.

The company is associated with 1 brand - Covidh Technologies. As per MCA filings, the company has satisfied charges of ₹1.6 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website covidh.com.

Company Details of Isera Lifesciences Limited
CIN L72200PN1993PLC252720
Registration Number 252720
Incorporation Date 27 January 1993
ROC Pune
Listing Status Listed (BSE: 534920)
Company Status Active
Date of Last AGM 26 August 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Office No A1 – 1202 12Th Floor Boulevard Towers Phase 2, Cts No 11 Sadhu Vaswani Chowk Camp, Pune City, Maharashtra, India – 411001
  • Industry
    Information Technology, Application Development & Software Solutions
Company report
Isera Lifesciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Isera Lifesciences Limited report

Financials, compliance, directors, charges, ownership and filings for Isera Lifesciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Isera Lifesciences Limited

Isera Lifesciences Limited has undergone 8 name changes throughout its history. The current legal name is Isera Lifesciences Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Isera Lifesciences Limited Current
Aarya Consultants Private Limited Previous
Fastrak Industries Limited Previous
Lordven Technologies Limited Previous
Lorden Technologies Limited Previous
Fastrak Capitals Limited Previous
Fastrak Capitals Private Limited Previous
Aptus Industries Limited Previous

CIN History of Isera Lifesciences Limited

Isera Lifesciences Limited has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L72200PN1993PLC252720, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L72200PN1993PLC252720 Current
L45400AP1993PLC015306 Previous
L72200TG1993PLC015306 Previous
L67120AP1993PLC015306 Previous
L72200AP1993PLC015306 Previous

Associated Brands with Isera Lifesciences Limited

Isera Lifesciences Limited operates one associated brand: Covidh Technologies. These brands represent Isera Lifesciences Limited's diversified market presence and brand portfolio.

Brand Description Website
IT solutions are offered by Covidh Technologies across various sectors. covidh.com

Competitors & Alternatives of Isera Lifesciences Limited

Brands and companies operating in the same space as Isera Lifesciences Limited include Happiest Minds, Mavenir, 1&1 IONOS and 6 more.

Competitor Description Location Founded
Happiest Minds Happiest Minds IT outsourcing services are delivered across multiple business lines. Bengaluru, India, India 2011
Mavenir Mavenir Multi-access edge networking computing platform is provided for mobile services. Richardson, United States, United States 2005
1&1 IONOS 1&1 IONOS Cloud infrastructure and hosting services are provided by 1&1 IONOS. Chesterbrook, United States, United States 1988
Datamatics Datamatics Cloud-based text analytics and cognitive automation services are provided. Mumbai, India, India 1975
Genpact Genpact Provider of end-to-end business process outsourcing services New York, United States, United States 1997
NTT DATA NTT DATA Application development, cloud, cybersecurity, and business intelligence services are provided. Koto City, Japan, Japan 1967
Endava Endava Endava is engaged in digital transformation and AI-driven solutions. London, United Kingdom, United Kingdom 2000
Accenture Accenture IT and management consultancy services are provided globally. Dublin, Ireland, Ireland 1989
UST UST High-quality office furniture is provided by UST for various needs. Taiwan 1998

Auditor Details of Isera Lifesciences Limited

Isera Lifesciences Limited is audited by GMKS & Co (ICAI peer reviewed, certificate valid till 2026-03-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
GMKS & Co (ICAI peer reviewed, certificate valid till 2026-03-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Isera Lifesciences Limited

Isera Lifesciences Limited is currently managed by 8 directors, with 33 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Mangina Rao Srinivas Director 30 May 2025 1 Years 1 Months Current
Jitendra Prabhakar Nene Director 24 Oct 2024 1 Years 8 Months Current
Jayshree Babulal Jain Managing Director 28 Aug 2024 1 Years 10 Months Current
Rinku Saini Director 01 Aug 2025 0 Years 11 Months Current
Pratap Dadasaheb Deshmukh Director 02 Apr 2026 0 Years 3 Months Current
Nandkumar Subhash Kadam Director 02 Apr 2026 0 Years 3 Months Current
Showing 6 of 8 current directors. View all directors

Financials of Isera Lifesciences Limited FY 2026 filings available

Isera Lifesciences Limited reported revenue of ₹1.36 Cr for FY 2026.

Revenue · FY 2026
₹1.36 Cr
Profit · FY 2026
₹25.94 Lakh ▲ 86.62%
Computed EBITDA · FY 2026
₹33.64 Lakh ▲ 142.01%
Revenue₹ Cr · Standalone051015FY 2019: ₹12 Cr12.3FY 2019FY 2021: ₹0 Cr · -100% YoY0-100%FY 2021FY 2022: ₹0 Cr0FY 2022FY 2023: ₹0 Cr0FY 2023FY 2024: ₹0 Cr0FY 2024FY 2025: ₹0 Cr0FY 2025FY 2026: ₹1 Cr1.4FY 2026
Net Profit₹ Cr · Standalone-0.3-0.2-0.100.10.20.3FY 2019: ₹0 Cr (loss)-0FY 2019FY 2021: ₹0 Cr (loss) · -1369.7% YoY-0.2FY 2021FY 2022: ₹0 Cr (loss) · +99% YoY-0FY 2022FY 2023: ₹0 Cr (loss) · -4760.9% YoY-0.1FY 2023FY 2024: ₹0 Cr (loss) · +11.6% YoY-0.1FY 2024FY 2025: ₹0 Cr · +240.7% YoY0.1+240.7%FY 2025FY 2026: ₹0 Cr · +86.6% YoY0.3+86.6%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year00.511.5Q1'25: ₹0 Cr0Q1'25Q2'25: ₹0 Cr0Q2'25Q3'25: ₹0 Cr0Q3'25Q4'25: ₹0 Cr0Q4'25Q1'26: ₹0 Cr0Q1'26Q2'26: ₹0 Cr0Q2'26Q3'26: ₹0 Cr0.2Q3'26Q4'26: ₹1 Cr1.2Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2019
Revenue from Operations ₹1.36 Cr ₹0 ₹0 ₹0 ₹0 ₹0 ₹12.3 Cr
Other Income ₹7.02 Lakh ₹26.52 Lakh ₹0 ₹0 ₹9,000 ₹8.49 Lakh ₹0
Total Income ₹1.43 Cr ₹26.52 Lakh ₹0 ₹0 ₹9,000 ₹8.49 Lakh ₹12.3 Cr
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹11.83 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹5.25 Lakh ₹0 ₹0 ₹0 ₹0 ₹4.41 Lakh ₹6.1 Lakh
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹2,000 ₹1.78 Lakh ₹22.81 Lakh
Depreciation & Amortisation ₹0 ₹0 ₹0 ₹0 ₹10,000 ₹9.88 Lakh ₹8.39 Lakh
Other Expenses ₹1.04 Cr ₹12.62 Lakh ₹9.88 Lakh ₹11.18 Lakh ₹18,000 ₹15.05 Lakh ₹8.66 Lakh
Total Expenses ₹1.09 Cr ₹12.62 Lakh ₹9.88 Lakh ₹11.18 Lakh ₹30,000 ₹31.12 Lakh ₹12.29 Cr
Profit Before Exceptional Items & Tax ₹33.64 Lakh ₹13.9 Lakh -₹9.88 Lakh -₹11.18 Lakh -₹21,000 -₹22.63 Lakh ₹88,000
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹33.64 Lakh ₹13.9 Lakh -₹9.88 Lakh -₹11.18 Lakh -₹21,000 -₹22.63 Lakh ₹88,000
Total Tax Expense ₹7.7 Lakh ₹0 ₹0 ₹0 ₹2,000 ₹15,000 ₹2.43 Lakh
Net Profit ₹25.94 Lakh ₹13.9 Lakh -₹9.88 Lakh -₹11.18 Lakh -₹23,000 -₹22.78 Lakh -₹1.55 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹25.94 Lakh ₹13.9 Lakh -₹9.88 Lakh -₹11.18 Lakh -₹23,000 -₹22.78 Lakh -₹1.55 Lakh
EBITDA (computed) ₹33.64 Lakh ₹13.9 Lakh -₹9.88 Lakh -₹11.18 Lakh -₹9,000 -₹10.97 Lakh ₹32.08 Lakh
Basic EPS ₹0.74 ₹4.34 ₹-3.29 ₹-3.73 ₹0.00 ₹-0.21 ₹-1.57
Diluted EPS ₹0.74 ₹4.34 ₹-3.29 ₹-3.73 ₹0.00 ₹-0.21 ₹-1.57
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2019
Total Assets ₹10.56 Cr ₹1.55 Cr ₹5.48 Lakh ₹5.06 Lakh ₹9,000 ₹4.5 Cr ₹17.66 Cr
Non-current Assets ₹6.24 Cr ₹0 ₹0 ₹0 ₹0 ₹4.5 Cr ₹90.1 Lakh
Current Assets ₹4.32 Cr ₹1.55 Cr ₹5.48 Lakh ₹5.06 Lakh ₹9,000 ₹31,000 ₹16.76 Cr
Property, Plant & Equipment ₹0 ₹0 ₹0 ₹0 ₹0 ₹42.77 Lakh ₹86.93 Lakh
Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Trade Receivables ₹1.2 Cr ₹31.29 Lakh ₹0 ₹0 ₹0 ₹0 ₹14.31 Cr
Cash & Equivalents ₹2.87 Cr ₹2.08 Lakh ₹14,000 ₹28,000 ₹9,000 ₹31,000 ₹42.94 Lakh
Equity (Net Worth) ₹8.25 Cr -₹9.8 Lakh -₹21.51 Lakh -₹11.62 Lakh -₹46,000 -₹11.54 Lakh ₹49.21 Lakh
Equity Share Capital ₹8.41 Cr ₹32.34 Lakh ₹30 Lakh ₹30 Lakh ₹30.1 Lakh ₹10.6 Cr ₹10.6 Cr
Borrowings (Non-current) ₹0 ₹1.61 Cr ₹18.44 Lakh ₹12.51 Lakh ₹0 ₹2.02 Cr ₹8.08 Cr
Borrowings (Current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹2.55 Cr
Total Debt (computed) ₹0 ₹1.61 Cr ₹18.44 Lakh ₹12.51 Lakh ₹0 ₹2.02 Cr ₹10.64 Cr
Current Liabilities ₹65.22 Lakh ₹4.62 Lakh ₹8.55 Lakh ₹4.17 Lakh ₹55,000 ₹2.56 Cr ₹9.09 Cr
Total Liabilities ₹2.32 Cr ₹1.65 Cr ₹26.99 Lakh ₹16.68 Lakh ₹55,000 ₹4.61 Cr ₹17.17 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹5.3 Cr -₹1.4 Cr -₹6.07 Lakh -₹12.33 Lakh ₹11.88 Cr
Investing Cash Flow ₹0 ₹0 ₹0 ₹0 ₹42.77 Lakh
Financing Cash Flow ₹8.14 Cr ₹1.42 Cr ₹0 ₹12.51 Lakh -₹12.31 Cr
Capital Expenditure ₹0 ₹0 ₹0 ₹0 ₹0
Free Cash Flow (computed) -₹5.3 Cr -₹1.4 Cr -₹6.07 Lakh -₹12.33 Lakh ₹11.88 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹2.85 Cr ₹1.84 Lakh -₹6.07 Lakh ₹18,000 -₹21,000
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹1.16 Cr ₹19.32 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Income ₹5.77 Lakh ₹25,000 ₹1 Lakh ₹0 ₹26.52 Lakh ₹0 ₹0 ₹0
Total Income ₹1.22 Cr ₹19.57 Lakh ₹1 Lakh ₹0 ₹26.52 Lakh ₹0 ₹0 ₹0
Cost of Materials Consumed ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹4.03 Lakh ₹68,000 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Finance Costs ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Depreciation & Amortisation ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Other Expenses ₹55.24 Lakh ₹47.09 Lakh ₹30,000 ₹1.54 Lakh ₹3.72 Lakh ₹6.65 Lakh ₹1.19 Lakh ₹1.06 Cr
Total Expenses ₹59.27 Lakh ₹47.77 Lakh ₹30,000 ₹1.54 Lakh ₹3.72 Lakh ₹6.65 Lakh ₹1.19 Lakh ₹1.06 Cr
Profit Before Exceptional Items & Tax ₹62.68 Lakh -₹28.2 Lakh ₹70,000 -₹1.54 Lakh ₹22.8 Lakh -₹6.65 Lakh -₹1.19 Lakh -₹1.06 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹62.68 Lakh -₹28.2 Lakh ₹70,000 -₹1.54 Lakh ₹22.8 Lakh -₹6.65 Lakh -₹1.19 Lakh -₹1.06 Cr
Total Tax Expense ₹7.7 Lakh ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Net Profit ₹54.98 Lakh -₹28.2 Lakh ₹70,000 -₹1.54 Lakh ₹22.8 Lakh -₹6.65 Lakh -₹1.19 Lakh -₹1.06 Cr
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹54.98 Lakh -₹28.2 Lakh ₹70,000 -₹1.54 Lakh ₹22.8 Lakh -₹6.65 Lakh -₹1.19 Lakh -₹1.06 Cr
EBITDA (computed) ₹62.68 Lakh -₹28.2 Lakh ₹70,000 -₹1.54 Lakh ₹22.8 Lakh -₹6.65 Lakh -₹1.19 Lakh -₹1.06 Cr
Basic EPS ₹1.58 ₹-2.02 ₹0.22 ₹-0.05 ₹7.13 ₹0.00 ₹0.00 ₹0.00
Diluted EPS ₹1.58 ₹-2.02 ₹0.22 ₹-0.05 ₹7.13 ₹0.00 ₹0.00 ₹0.00
Latest 8 quarters shown.
Metrics FY 2020 FY 2019
Revenue from Operations ₹2.13 Cr ₹25.69 Cr
Other Income ₹0 ₹0
Total Income ₹2.13 Cr ₹25.69 Cr
Cost of Materials Consumed ₹2.05 Cr ₹25.03 Cr
Purchases of Stock-in-Trade ₹0 ₹0
Changes in Inventories ₹0 ₹0
Employee Benefit Expense ₹5.65 Lakh ₹7.37 Lakh
Finance Costs ₹22.25 Lakh ₹38.01 Lakh
Depreciation & Amortisation ₹12.29 Lakh ₹11.82 Lakh
Other Expenses ₹7.61 Lakh ₹9.78 Lakh
Total Expenses ₹2.53 Cr ₹25.7 Cr
Profit Before Exceptional Items & Tax -₹39.94 Lakh -₹1.9 Lakh
Exceptional Items ₹0 ₹0
Profit Before Tax -₹39.94 Lakh -₹1.9 Lakh
Total Tax Expense ₹1.8 Lakh ₹2.43 Lakh
Net Profit -₹41.74 Lakh -₹4.33 Lakh
  attributable to Owners ₹0 -
  attributable to NCI ₹0 -
Other Comprehensive Income ₹0 ₹0
Total Comprehensive Income -₹41.74 Lakh -₹4.33 Lakh
EBITDA (computed) -₹5.4 Lakh ₹47.93 Lakh
Basic EPS ₹-41.75 ₹-0.04
Diluted EPS ₹-41.75 ₹-0.04
Metrics FY 2020 FY 2019
Total Assets ₹10.47 Cr ₹17.66 Cr
Non-current Assets ₹62.26 Lakh ₹90.1 Lakh
Current Assets ₹9.85 Cr ₹16.76 Cr
Property, Plant & Equipment ₹62.26 Lakh ₹86.93 Lakh
Inventories ₹0 ₹0
Trade Receivables ₹8.58 Cr ₹14.31 Cr
Cash & Equivalents ₹92,000 ₹42.94 Lakh
Equity (Net Worth) ₹11.24 Lakh ₹49.21 Lakh
Equity Share Capital ₹10.6 Cr ₹10.6 Cr
Borrowings (Non-current) ₹6.56 Cr ₹8.08 Cr
Borrowings (Current) ₹0 ₹2.55 Cr
Total Debt (computed) ₹6.56 Cr ₹10.64 Cr
Current Liabilities ₹3.76 Cr ₹9.09 Cr
Total Liabilities ₹10.36 Cr ₹17.17 Cr
Metrics
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Isera Lifesciences Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Charges & Borrowings of Isera Lifesciences Limited

Open charges
₹0
Satisfied charges
₹1.6 Cr
Breakdown by lending institutions
Andhra Bank₹1.60 Cr
Latest charge details
DateLenderAmountStatus
01 Jul 2015 Andhra Bank ₹1.6 Cr Satisfied

Total charge records: 1 View all charges

Employees and EPFO Compliance at Isera Lifesciences Limited

View historical data on people associated with Isera Lifesciences Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Isera Lifesciences Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Isera Lifesciences Limited

Premium access

GST registrations and filing compliance for Isera Lifesciences Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Isera Lifesciences Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Isera Lifesciences Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Isera Lifesciences Limited

Premium access

MSME payment history for Isera Lifesciences Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Isera Lifesciences Limited

Premium access

Corporate group structure for Isera Lifesciences Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Isera Lifesciences Limited

Premium access

MCA filings and documents for Isera Lifesciences Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Isera Lifesciences Limited

Directors
02 Apr 2026
Pratap Dadasaheb Deshmukh was appointed as a Director on 02 Apr 2026 & has been associated with this company since 3 months 14 days.
Directors
02 Apr 2026
Nandkumar Subhash Kadam was appointed as a Director on 02 Apr 2026 & has been associated with this company since 3 months 14 days.
Directors
02 Apr 2026
Dhairyasheel Vasantrao Yadav was appointed as a Director on 02 Apr 2026 & has been associated with this company since 3 months 14 days.
Directors
02 Apr 2026
Ritu Dhanraj Garad was appointed as a Director on 02 Apr 2026 & has been associated with this company since 3 months 14 days.
Directors
11 Sep 2025
Deepakshi was appointed as a Company Secretary on 11 Sep 2025 & has been associated with this company since 10 months 3 days.
Activity
26 Aug 2025
Isera Lifesciences Limited last Annual general meeting of members was held on 26 Aug 2025 as per latest MCA records.

Frequently Asked Questions about Isera Lifesciences Limited

Isera Lifesciences Limited is an active public limited company in the information technology sector based in Pune City, Maharashtra, India. It was incorporated on 27 January 1993 (33+ years old) and is registered under CIN L72200PN1993PLC252720. Listed on BSE: 534920. The company has 1 employees.

Isera Lifesciences Limited reported revenue of ₹1.36 Cr for FY 2026 based on standalone BSE filings.

The current directors of Isera Lifesciences Limited are:

The primary industry of Isera Lifesciences Limited is information technology. The company specifically operates in application development and software solutions. The company is currently active in this sector.

Yes. Isera Lifesciences Limited is listed on BSE with code 534920.

Isera Lifesciences Limited can be reached at the registered office: Office No A1 – 1202 12Th Floor Boulevard Towers Phase 2, Cts No 11 Sadhu Vaswani Chowk Camp, Pune City, Maharashtra, India – 411001, or through the website covidh.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available